Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005633 220002204 1.92 74.6 Curative (C) 2013-01-16 2013-02-06 AML17 TRIAL Y N 220028630 AML17 TRIAL
220005634 220002204 1.72 57.2 Disease modification (D) 2013-06-13 2013-06-22 Trial Unspecified Y N 220028630 TRIAL
220005635 220021224 1.75 71.2 Not known (9) 2013-12-11 2013-12-11 AML17 TRIAL 02 N 220028639 AML17 TRIAL
220005636 220021224 1.58 null Palliative (P) 2015-08-11 2015-08-14 Cytarabine low (10to20mg/m2) IV/SC N null 220028639 CYTARABINE
220005638 220002206 null 59.6 Curative (C) 2016-02-15 2016-02-19 AML17 TRIAL 01 N 220028644 AML17 TRIAL
220005641 220002208 1.67 84.8 Disease modification (D) 2015-01-23 2015-01-23 LI-1 TRIAL N N 220028649 TRIAL
220005642 220002208 1.65 68 Curative (C) 2018-03-27 2018-03-27 AML17 TRIAL 01 N 220028649 AML17 TRIAL
220005643 220002208 null 53.7 Curative (C) 2016-08-18 2016-08-22 AML17 TRIAL N N 220028649 AML17 TRIAL
220005644 220002208 null 62.3 null 2016-10-11 2016-10-17 Trial Unspecified Y N 220028649 TRIAL
220005645 220002209 1.68 59.7 Curative (C) 2014-03-16 2014-03-16 AML17 TRIAL 01 N 220028662 AML17 TRIAL
220005646 220002210 null null Palliative (P) 2013-09-13 2014-09-19 Cytarabine Low Dose N N 220028663 CYTARABINE
220005647 220002211 1.75 60 Curative (C) 2014-12-03 2014-12-03 AML17 TRIAL Y N 220028665 AML17 TRIAL
220005648 220002211 1.64 84.5 Curative (C) 2017-07-24 2017-07-24 AML17 TRIAL 1 N 220028665 AML17 TRIAL
220005649 220002211 1.85 0 Palliative (P) null 2017-08-25 Cytarabine Low Dose 02 N 220028665 CYTARABINE
220005650 220002211 1.7 null Curative (C) 2015-05-08 2015-05-10 AML17 TRIAL Y N 220028665 AML17 TRIAL
220005651 220002212 1.8 95.2 Palliative (P) 2014-11-24 2014-12-18 Cytarabine low (10to20mg/m2) IV/SC N N 220028671 CYTARABINE
220005652 220002213 1.82 71.5 Adjuvant (A) 2014-05-11 2014-05-11 LI-1 TRIAL Y N 220028673 TRIAL
220005653 220011213 1.85 70.3 Palliative (P) 2014-11-04 2016-05-20 Cytarabine low (10to20mg/m2) IV/SC N N 220028675 CYTARABINE
220005654 220016006 1.56 null null 2014-11-02 2014-11-02 Trial Unspecified Y N 220028676 TRIAL
220005655 220002214 1.83 null Palliative (P) 2013-03-15 2013-04-03 Cytarabine Intrathecal (any age) N N 220028677 CYTARABINE
220005656 220002215 null null null 2016-01-14 2016-01-17 Cytarabine Low Dose 2 N 220028679 CYTARABINE
220005657 220002215 1.58 0 Palliative (P) null 2016-03-05 CYTARABINE null null 220028679 CYTARABINE
220005658 220002216 null 0 null 2016-12-16 2016-12-27 Cytarabine Low Dose N null 220028683 CYTARABINE
220005659 220002216 1.77 52.2 Curative (C) 2013-10-19 2013-10-19 AML17 TRIAL null null 220028683 AML17 TRIAL
220005660 220016007 1.59 45.7 null 2014-01-22 2014-01-28 Cytarabine Low Dose N N 220028685 CYTARABINE
220005661 220002217 1.73 74.6 Curative (C) 2016-08-31 2016-08-31 AML17 TRIAL Y N 220028687 AML17 TRIAL
220005662 220002218 1.75 null Palliative (P) 2015-05-22 2015-05-22 Trial Unspecified Y N 220028689 TRIAL
220005663 220002218 null 65 null 2016-07-05 2016-07-10 Cytarabine Low Dose 02 null 220028689 CYTARABINE
220005664 220002218 1.75 70 Curative (C) 2015-09-25 2015-10-01 Cytarabine Low Dose N Y 220028689 CYTARABINE
220005665 220002219 1.82 60 Palliative (P) 2019-03-19 2019-03-19 Cytarabine Low Dose null null 220028694 CYTARABINE
220005666 220011217 1.77 7 Palliative (P) 2015-04-07 2015-04-07 Cytarabine Low Dose N N 220028695 CYTARABINE
220005667 220011217 1.67 null Disease modification (D) 2014-05-07 2014-05-07 Cytarabine Low Dose N N 220028695 CYTARABINE
220005668 220002220 1.57 95.4 Curative (C) 2015-08-04 2015-08-10 Trial Unspecified 1 N 220028704 TRIAL
220005669 220002220 null 108.4 Disease modification (D) 2017-01-06 2017-01-06 LI-1 TRIAL Y N 220028704 TRIAL
220005670 220002220 null 78 Curative (C) null 2016-05-01 Trial Unspecified Y N 220028704 TRIAL
220005671 220002220 1.72 59.7 Not known (9) 2016-06-17 2016-07-06 AML17 TRIAL N N 220028704 AML17 TRIAL
220005672 220002221 null null Curative (C) 2014-06-12 2014-06-12 Trial Unspecified 1 N 220028709 TRIAL
220005673 220002221 0 54.8 Not known (9) 2014-05-06 2014-05-08 AML17 TRIAL N N 220028709 AML17 TRIAL
220005674 220002221 null 60 null 2015-09-19 2015-10-05 Trial Unspecified Y N 220028709 TRIAL
220005675 220002221 null 58.8 null 2015-06-30 2015-07-07 CYTARABINE N N 220028709 CYTARABINE
220005676 220002221 1.78 null null 2013-06-08 2013-06-08 Cytarabine Low Dose Y null 220028709 CYTARABINE
220005677 220002221 1.73 54 Disease modification (D) null 2016-08-20 LI-1 TRIAL N N 220028709 TRIAL
220005678 220002221 1.73 null null 2013-06-19 2013-06-19 Cytarabine low (10to20mg/m2) IV/SC N N 220028709 CYTARABINE
220005680 220002223 0 0 Palliative (P) 2013-04-10 2013-04-11 CYTARABINE 02 N 220028723 CYTARABINE
220005681 220002224 1.69 70.4 Curative (C) 2013-05-18 2013-05-20 Trial Unspecified Y N 220028724 TRIAL
220005682 220002225 1.75 87 Curative (C) 2013-09-21 2013-09-22 AML17 TRIAL N N 220028725 AML17 TRIAL
220005684 220002226 null null Curative (C) 2017-04-26 2017-04-26 Trial Unspecified Y N 220028729 TRIAL
220005685 220002226 null null Palliative (P) 2013-05-09 2013-05-09 Cytarabine Low Dose 02 N 220028729 CYTARABINE
220005686 220002226 1.49 68 Curative (C) 2016-05-07 2016-05-07 Trial Unspecified Y null 220028729 TRIAL
220005687 220002227 1.77 83.3 Disease modification (D) 2015-03-22 2015-03-22 Trial Unspecified N N 220028735 TRIAL